(+961) 1 421 000 ext adel.tabshy@usj.edu.lb
| Diplôme | Université | Pays | Année |
|---|---|---|---|
| MEDICAL ONCOLOGY FELLOWSHIP DIPLOMA | The University of Texas MD Anderson Cancer Center | Etats-Unis | 2010 |
| RESIDENCY IN INTERNAL MEDICINE DIPLOMA | Boston University | Etats-Unis | 2007 |
| The American Board of Internal Medicine Diploma | The American Board of Internal Medicine | Etats-Unis | 2007 |
| MASTERS OF SCIENCE IN BIOENGINEERING DIPLOMA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Etats-Unis | 2004 |
| MD Diploma | American University of Beirut (AUB) | Liban | 2001 |
| Bachelor of Science Diploma | American University of Beirut (AUB) | Liban | 1997 |
I teach about Cancer Pathophysiology. I teach cancer Epidemiology Risk factors. I teach about Breast cancer diagnosis Management.
| Enseignement universitaire hors USJ | Pays | Etablissement | Date début | Date fin |
|---|---|---|---|---|
| Medical Oncology, Professor of Medicine | Etats-Unis | Washington University in St Louis, School of Medicine | 01/01/2013 | 01/03/2015 |
| Medical Oncology, Faculty Member | Etats-Unis | The University of Texas MD ANDERSON CANCER CENTER | 01/07/2007 | 01/07/2011 |
| Expérience professionnelle | Organisation | Date début | Date fin |
|---|---|---|---|
| Attending Physician, Medical Oncology, Professor of Medicine | Washington University in St Louis, School of Medicine | 01/01/2013 | 01/03/2015 |
| Attending Physician, Medical Oncology, Faculty Member | MD ANDERSON CANCER CENTER, HOUSTON, TX | 01/07/2007 | 01/07/2011 |
Médecine et Santé
I am the recipient of NIH grants to investigate pathologic processes at the molecular level in Breast cancers. I am a clinical translational researcher. I investigate breast cancers.
Adel Tabchy, Vicente Valero, Tatiana Vidaurre, Ana Lluch, Henry Gomez, Miguel Martin, Yuan Qi, Luis Javier Barajas-Figueroa, Eduardo Souchon, Charles Coutant, Franco D Doimi, Nuhad K Ibrahim, Yun Gong, Gabriel N Hortobagyi, Kenneth R Hess, W Fraser Symmans, Lajos Pusztai. Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. Clinical Cancer Research. 2010 Nov 116(21):5351-61. Epub 2010 Sep 9. - For rest of publications, see CV.